LUNGevity Foundation is proud to be the largest lung cancer-focused private funder of research in the United States and is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as providing community, support, and education for all those affected by the disease. We invest in research in both early detection and targeted therapeutics.
February 02, 2021
Article
A survey conducted by the LUNGevity Foundation determined that 96% of patients with lung cancer felt that they were concerned about the COVID-19 pandemic affecting their treatment.
December 05, 2017
Article
Patient Advocacy Summit brings together advocacy organizations and other key stakeholders to share ideas about how to improve survivors’ quality of life.
May 12, 2015
Article
Lung cancer is the deadliest cancer killer, claiming more lives than the next four major cancers combined, but believe it or not, there are many reasons to be hopeful.
The COVID-19 Pandemic Has Reminded Us All About the Importance of a Phone Call
Team Efforts Propel Cancer Victories
FDA Authorizes Johnson & Johnson’s Single-Dose COVID-19 Vaccine, Marking Third Vaccine in US
How Life Lessons from My Parents, a Former Employer and a Holocaust Survivor Have Helped Me During My Cancer Journey